Ket-a-xyl
Komposition
Xilazine chlorhydrate (equivalent to base) 20 mg, ketamine chlorhydrate (equivalent to base) 100 mg, atropine sulphate (equivalent to base) 1 mg, excipients q.s. ad 1 mL.
Verschreibung
Neuroleptoanalgesic association
Indikation
The association ketamine-xilazine generates neuroleptoanalgesia that permits to effect a safe surgycal handling (abdominal cavity, muscles, castration, deep cleaning of mucous tissues, teeth and surgycal cleaning of abscesses). It provides non dissociativ
Kontra-Indikationen
Cant be used on animals with hyper sensibility
Nebenwirkungen
can produce pain in the application area
Dosierung
Only by intramuscular route, at a rate of 5 mg-10 mg ketamine/kg of body weignt, 1 mg-2 mg xilacine/kg of body weight and 0.05 mg-0.1 mg atropine/kg body weight; which in practice is equivalent to 0.5 mL-1 mL/10 Kg. body weight.
Rückruf-Zeiten
none
Verpackung
Glass vial of 10 mL, glass vial of 20 mL, glass vial of 30 mL
